Published on 4 Mar 2024 on GuruFocus.com via Yahoo Finance
Insider Sell: CFO Bruce Jacobs Sells 3,934 Shares of Kymera Therapeutics Inc (KYMR)
Kymera Therapeutics Inc (NASDAQ:KYMR) CFO Bruce Jacobs has sold 3,934 shares of the company's stock on March 4, 2024, according to a recent SEC filing. The transaction was executed at an average price of $41.86 per share, resulting in a total value of $164,725.24.
Kymera Therapeutics Inc is a biotechnology company focused on discovering and developing novel small molecule therapeutics that modulate protein degradation pathways. These therapies are designed to address a wide range of diseases and conditions.
Warning! GuruFocus has detected 6 Warning Signs with KYMR.